Abstract:Topic: 22. Stem cell transplantation - Clinical Background: As a rare but life-threatening critical complication following allogenic haematopoietic stem cell transplantation (allo-HSCT), liver failure is significantly related to poor survival and increased non-relapse mortality. Therefore, identifying patients at high risk of death who should receive specific therapeutic management is key to improving their survival. Here, we established the first clinical prognostic model to predict post-transplant liver failure prognosis to facilitate physician decision-making. Aims: This study was aimed at establishing a prognostic model for selecting post-transplant patients who are at a higher risk of liver failure and disease mortality. Methods: We retrospectively evaluated 113 consecutive liver failure patients who underwent allo-HSCT at a single centre between 2010 and 2022. These patients were further randomly divided into a derivation cohort of 57 patients and a validation cohort of 56 patients. Pearson’s chi-square test and Fisher’s exact test were applied to compare the categorical variables. Outcomes described by the cumulative incidence of overall survival (OS), non-relapse mortality (NRM) and relapse were evaluated by Kaplan-Meier method and the log-rank test. We assessed the prognostic model performance by evaluating the discrimination [area under the curve (AUC)], calibration (calibration plot), and net benefit [decision curve analysis (DCA)]. Results: In total, 113 of 16819 patients (0.67%) were diagnosed with liver failure after transplantation. Disseminated intravascular coagulation (DIC), viral hepatitis, acute kidney injury (AKI), gastrointestinal disease or bleeding, poor platelet implantation, and chronic graft versus host disease (cGHVD) were determined to be significant risk factors for the occurrence of liver failure after allo-HSCT. Because of the higher mortality rate after liver failure, these factors are also significantly related to mortality in patients with liver failure after allo-HSCT. The AUCs of the model were 0.887 (95% CI 0.833-0.940) and 0.770 (0.701-0.839) for the training and validation cohorts, respectively. The calibration plots showed high consistency between the predicted and observed outcomes. Patients were further classified into low-risk and high-risk categories while considering the observed death distribution of the total cohort by tertiles of 2-year outcome probability according to the score. Significant differences in Kaplan-Meier estimations of overall survival were obtained. Summary/Conclusion: The predictive models developed for the occurrence and mortality of liver failure performed well in terms of discrimination, and they might assist clinicians with personalized strategies for liver failure prevention and treatment in patients after allo-HSCT. Keywords: Liver, Allogeneic hematopoietic stem cell transplant, Prognostic factor

Nomogram for Predicting Early Mortality after Umbilical Cord Blood Transplantation in Children with Inborn Errors of Immunity

A Predictive Model Combining Clinical Characteristics and Nutritional Risk Factors for Overall Survival after Umbilical Cord Blood Transplantation.

Value of Nomogram in Early Prediction of Death in Patients Post Extracorporeal Membrane Oxygenation

A Statistical Prediction Model for Survival after Kidney Transplantation from Deceased Donors

A Risk Score for Mortality after Allogeneic Hematopoietic Cell Transplantation

A Recipient Risk Prediction Tool for Short-term Mortality After Pediatric Heart Transplantation

A Nomogram for Predicting Death for Infants Born at a Gestational Age of <28 Weeks: a Population-Based Analysis in 18 Neonatal Intensive Care Units in Northern China

Development and Validation of a Nomogram to Predict Allograft Survival after Pediatric Liver Transplantation.

A novel prognostic model based on serum levels of total bilirubin and creatinine early after liver transplantation.

European Group for Blood and Marrow Transplantation Risk Score Predicts the Outcome of Patients with Acute Leukemia Receiving Single Umbilical Cord Blood Transplantation

Development and validation of a model for early survival prediction following liver transplantation based on donor and recipient characteristics

Development and Validation of a Risk Prediction Model for In-Hospital Mortality in Patients With Acute Upper Gastrointestinal Bleeding

A nomogram for prediction of early mortality in patients undergoing cardiac surgery for infective endocarditis: a retrospective single-center study

Predicting mortality from intracranial hemorrhage in patients who undergo allogeneic hematopoietic stem cell transplantation

Identification of Neonatal Factors Predicting Pre-Discharge Mortality in Extremely Preterm or Extremely Low Birth Weight Infants: A Historical Cohort Study

Improve the Prediction of Liver Transplant Mortality Based on Pre-Transplant Factors: A Multi-Center Study from China: Mortality Prediction of LT.

PB2409: CLINICAL PROGNOSTIC MODEL OF LIVER FAILURE AFTER ALLOGENEIC HAEMATOPOIETIC STEM CELL TRANSPLANTATION

Prognostic Factors and Outcome of Patients Undergoing Hematopoietic Stem Cell Transplantation Who Are Admitted to Pediatric Intensive Care Unit

Development of a quantitative prediction algorithm for human cord blood-derived CD34+ hematopoietic stem-progenitor cells using parametric and non-parametric machine learning models

A nomogram prediction model for early death in patients with persistent pulmonary hypertension of the newborn

Machine Learning–Based Risk Model for Predicting Early Mortality after Surgery for Infective Endocarditis